News

RAANANA, Israel, Aug. 13, 2021 (GLOBE NEWSWIRE) -- Trigone Pharma Ltd. a leader in the field of urological diseases, today announced the initiation of a Phase 2 study of TRG-100 in patients with ...
Relmada Therapeutics Licenses Phase 2 Bladder Cancer Candidate, NDV-01, from Trigone Pharma, Ltd.
RAANANA, Israel, July 22, 2021 (GLOBE NEWSWIRE) -- Trigone Pharma Ltd., a privately owned biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients ...
The subventricular zone (SVZ) is a principal source of adult neural stem cells in the rodent brain, generating thousands of olfactory bulb neurons every day 1. If the adult human brain contains a ...
Patients with tumors in the trigone and urethra were more likely to experience recurrence and cancer-specific death after radical cystectomy than patients with tumor only in the bladder walls.